title: Critical appraisal of locoregional failure and systemic disease progression after preoperative chemoradiation of esophageal adenocarcinoma. Reply to R. Gertler et al.
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Kazuki
authors.initials: K
authors.lastname: Sudo
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Elena
authors.initials: E
authors.lastname: Elimova
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Heath D
authors.initials: HD
authors.lastname: Skinner
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Wayne L
authors.initials: WL
authors.lastname: Hofstetter
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX jajani@mdanderson.org.
authors.forename: Jaffer A
authors.initials: JA
authors.lastname: Ajani
mesh_terms: D000230:Adenocarcinoma / Q000628:therapy*; D059186:Chemoradiotherapy, Adjuvant; D004938:Esophageal Neoplasms / Q000628:therapy*; D016629:Esophagectomy; D005260:Female; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D016879:Salvage Therapy